Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Colorectal Cancer Screening · Screening for Colon Cancer · MRKR

ME Therapeutics

Marker Therapeutics

ME Therapeutics patent portfolio — 27 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Vancouver, British Columbia, CA HQ
2018 Founded
4 Employees
Public company Type
MRKR · NYSE Ticker
Company details
Status
Public
HQ
Vancouver, British Columbia, CA
Founded
2018
Employees
4
Programs
13
Drugs
10
Patents
27
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

ME Therapeutics patents

27 pharmaceutical patents indexed for ME Therapeutics. 2 expire within 24 months.

ME Therapeutics has 27 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

27 patents

Patent portfolio

  1. US 12077601

    Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11885817

    Biomarkers and methods for detection of seizures and epilepsy

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11692030

    Biomarkers and methods for detection of seizures and epilepsy

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11598782

    Biomarkers and methods for detection of seizures and epilepsy

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11447500

    Thienopyridine derivatives and pharmaceutical composition comprising same

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11186873

    Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11078298

    Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11008622

    Biomarker for predicting sensitivity to EGFR-targeting agent, and use thereof

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10543282

    Targeted peptide conjugates

    Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10444237

    Anti-pancreatic cancer monoclonal antibody and use thereof

    Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10401361

    Intracellular organelle peptide targeted enzyme substrates

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10016476

    Nutrient combinations for affecting an aging process

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9925271

    Targeted pharmacological chaperones

    Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9841426

    Intracellular organelle peptide targeted enzyme substrates

    Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9682132

    Compositions and methods relating to argininosucccinate synthetase

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9610358

    Targeted pharmacological chaperones

    Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9138453

    Nutrient combinations for affecting an aging process

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8900880

    Viral citrullinated peptides and uses thereof

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8692051

    Methods for testing for caloric restriction (CR) mimetics

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8436224

    Methods for testing for caloric restriction (CR) mimetics

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8403844

    Methods for interventions

    Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7960605

    Methods for testing for caloric restriction (CR) mimetics

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7306632

    Leave-in color conditioner

    Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7087095

    Hair coloring composition and method

    Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7060113

    Hair coloring composition and method

    Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 6656917

    Compositions and methods for targeted enzymatic release of cell regulatory compounds

    Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6506374

    Hair coloring composition and method

    Expires Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does ME Therapeutics have?

27 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ME Therapeutics patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.